drugset / Trial / NCT00787111
Extended Management and Measurement of Autism
NaSingle-groupOpen-labelTreatment
Summary
This open-label research study will continue to monitor the safety of fluoxetine in children after their completion of a previous double-blind placebo controlled clinical study, with fluoxetine. The study will also look at the effect of fluoxetine on IQ (Intelligence Quotient) over an 18 month period.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | 2 mg | Oral |
| Subject | Fluoxetine | Small molecule | 4 mg | Oral |
| Subject | Fluoxetine | Small molecule | 54 mg | Oral |